Founded Date: 6-26
Last Funding Type: Grant
Headquarters: New York, New York, United States
Investors Number: 5
Technology: Regenerative Medicine
Employee Number: 11-50
Industry: Neuropharmacology
Estimated Revenue: Less than $1M
Number Of Exists: Grant
Funding Status: N/A
Investor Type: Company
Investment Stage: N/A
Total Funding: $51.6M